Medication associated with Osteoporosis

Osteoporosis is a disease of bone that leads to an increased risk of fracture. In osteoporosis the bone mineral density (BMD) is reduced, bone microarchitecture is disrupted, and the amount and variety of non-collagenous proteins in bone is altered. Osteoporosis is defined by the World Health Organization (WHO) in women as a bone mineral density 2.5 standard deviations below peak bone mass (20-year-old healthy female average) as measured by DXA; the term "established osteoporosis" includes the presence of a fragility fracture.

This summary is for information purposes only, and NOT a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The following drugs and medications are in some way related to, or used in the treatment of Osteoporosis .